Netherlands· NL-76dc0660c523
Cervarix, suspensie voor injectie
A humaner papillomvirus (typen 16, 18) product containing recombinant humaan papillomavirus type 16-l1 proteïne + recombinant humaan papillomavirus type 18-l1 proteïne, registered in Netherlands by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Humaner papillomvirus (typen 16, 18) is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BM02 (humaner papillomvirus (typen 16, 18)), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Humaner papillomvirus (typen 16, 18) · ATC J07BM02
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 16-L1 PROTEÏNE + RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 18-L1 PROTEÏNE
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Netherlands (NL)
- ATC code
- J07BM02
- ATC class
- Humaner Papillomvirus (Typen 16, 18)
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/07/419
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BM02
Humaner papillomvirus (typen 16, 18), as other registers publish it.
- IcelandCervarixGlaxoSmithKline Biologicals S.A.*
- PolandCervarixGlaxoSmithKline Biologicals S.A.
- BelgiumCervarixGlaxoSmithKline Biologicals
- FinlandCervarixGlaxoSmithKline Biologicals SA
- PolandCervarixGlaxoSmithKline Biologicals S.A.
- IcelandCervarixGlaxoSmithKline Biologicals S.A.*
- BelgiumCervarixGlaxoSmithKline Biologicals
- IcelandCervarixGlaxoSmithKline Biologicals S.A.*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df8c661c-2f54-4527-b41b-be9ae41356cc GET /v1/drugs/df8c661c-2f54-4527-b41b-be9ae41356cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspensie voor injectie",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/cervarix-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Papillomavirus (human types 16, 18)",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73202",
"excipients": [
"3-O-DESACYL-4'-MONOFOSFORYLLIPIDE A",
"ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
"NATRIUMCHLORIDE",
"NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
"WATER VOOR INJECTIE"
],
"substances": [
"RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 16-L1 PROTEÏNE",
"RECOMBINANT HUMAAN PAPILLOMAVIRUS TYPE 18-L1 PROTEÏNE"
],
"leaflet_url": null,
"authorised_at": "2007/09/20",
"procedure_number": "EMEA/H/C/000721",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/07/419",
"additional_monitoring": "N"
}See everything about humaner papillomvirus (typen 16, 18).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.